Variant report

Variant	nsv581468
Chromosome Location	chr2:36687111-36715689
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:36709636-36710019	HepG2	liver:	n/a	n/a
2	ARID3A	chr2:36686830-36687284	HepG2	liver:	n/a	n/a
3	ARID3A	chr2:36713716-36714358	HepG2	liver:	n/a	chr2:36714223-36714239
4	ARID3A	chr2:36710379-36710400	HepG2	liver:	n/a	n/a
5	ATF2	chr2:36688297-36688732	H1-hESC	embryonic stem cell:	n/a	n/a
6	ATF3	chr2:36705370-36705911	A549	lung:	n/a	n/a
7	ATF3	chr2:36705308-36705929	A549	lung:	n/a	n/a
8	BACH1	chr2:36688465-36688763	H1-hESC	embryonic stem cell:	n/a	n/a
9	BACH1	chr2:36694232-36694257	H1-hESC	embryonic stem cell:	n/a	n/a
10	BCL3	chr2:36705230-36706085	A549	lung:	n/a	chr2:36705586-36705595
11	BCL3	chr2:36713511-36714430	A549	lung:	n/a	n/a
12	BCL3	chr2:36712369-36713290	A549	lung:	n/a	n/a
13	BHLHE40	chr2:36692362-36692415	K562	blood:	n/a	n/a
14	BRCA1	chr2:36686845-36687189	HepG2	liver:	n/a	n/a
15	CCNT2	chr2:36705461-36705603	K562	blood:	n/a	n/a
16	CEBPB	chr2:36713854-36714204	MCF-7	breast:	n/a	n/a
17	CEBPB	chr2:36709644-36710089	MCF-7	breast:	n/a	chr2:36709841-36709850 chr2:36709841-36709850 chr2:36709839-36709852 chr2:36709841-36709850
18	CEBPB	chr2:36709698-36710005	H1-hESC	embryonic stem cell:	n/a	chr2:36709841-36709850 chr2:36709841-36709850 chr2:36709839-36709852 chr2:36709841-36709850
19	CEBPB	chr2:36713875-36714183	A549	lung:	n/a	n/a
20	CEBPB	chr2:36713887-36714233	HepG2	liver:	n/a	n/a
21	CEBPB	chr2:36688414-36688822	Hela-S3	cervix:	n/a	n/a
22	CEBPB	chr2:36713695-36714249	IMR90	lung:	n/a	n/a
23	CEBPB	chr2:36700421-36700735	K562	blood:	n/a	chr2:36700540-36700551
24	CEBPB	chr2:36695597-36696173	IMR90	lung:	n/a	n/a
25	CEBPB	chr2:36705334-36705850	A549	lung:	n/a	n/a
26	CEBPB	chr2:36713754-36714318	A549	lung:	n/a	n/a
27	CEBPB	chr2:36709591-36710099	ECC-1	luminal epithelium:	n/a	chr2:36709841-36709850 chr2:36709841-36709850 chr2:36709839-36709852 chr2:36709841-36709850
28	CEBPB	chr2:36688347-36688652	H1-hESC	embryonic stem cell:	n/a	n/a
29	CEBPB	chr2:36712791-36713201	A549	lung:	n/a	n/a
30	CEBPB	chr2:36700372-36700728	HepG2	liver:	n/a	chr2:36700540-36700551
31	CEBPB	chr2:36687074-36687273	HepG2	liver:	n/a	n/a
32	CEBPB	chr2:36709634-36710150	A549	lung:	n/a	chr2:36709841-36709850 chr2:36709841-36709850 chr2:36709839-36709852 chr2:36709841-36709850
33	CEBPB	chr2:36709676-36710013	K562	blood:	n/a	chr2:36709841-36709850 chr2:36709841-36709850 chr2:36709839-36709852 chr2:36709841-36709850
34	CEBPB	chr2:36711563-36711820	Hela-S3	cervix:	n/a	n/a
35	CEBPB	chr2:36712614-36713278	Hela-S3	cervix:	n/a	n/a
36	CEBPB	chr2:36713488-36714451	A549	lung:	n/a	n/a
37	CEBPB	chr2:36712475-36713372	A549	lung:	n/a	n/a
38	CEBPB	chr2:36709654-36710038	A549	lung:	n/a	chr2:36709841-36709850 chr2:36709841-36709850 chr2:36709839-36709852 chr2:36709841-36709850
39	CEBPB	chr2:36709614-36710140	MCF-7	breast:	n/a	chr2:36709841-36709850 chr2:36709841-36709850 chr2:36709839-36709852 chr2:36709841-36709850
40	CEBPB	chr2:36711578-36711777	HepG2	liver:	n/a	n/a
41	CEBPB	chr2:36709699-36709937	HepG2	liver:	n/a	chr2:36709841-36709850 chr2:36709841-36709850 chr2:36709839-36709852 chr2:36709841-36709850
42	CEBPB	chr2:36688395-36688717	A549	lung:	n/a	n/a
43	CEBPB	chr2:36700342-36700781	Hela-S3	cervix:	n/a	chr2:36700540-36700551
44	CEBPB	chr2:36709654-36710047	ECC-1	luminal epithelium:	n/a	chr2:36709841-36709850 chr2:36709841-36709850 chr2:36709839-36709852 chr2:36709841-36709850
45	CEBPB	chr2:36713720-36714392	MCF-7	breast:	n/a	n/a
46	CEBPB	chr2:36709648-36710037	Hela-S3	cervix:	n/a	chr2:36709841-36709850 chr2:36709841-36709850 chr2:36709839-36709852 chr2:36709841-36709850
47	CEBPB	chr2:36709713-36710054	HepG2	liver:	n/a	chr2:36709841-36709850 chr2:36709841-36709850 chr2:36709839-36709852 chr2:36709841-36709850
48	CEBPB	chr2:36712670-36713302	A549	lung:	n/a	n/a
49	CEBPB	chr2:36700385-36700764	IMR90	lung:	n/a	chr2:36700540-36700551
50	CEBPB	chr2:36709489-36710229	A549	lung:	n/a	chr2:36709841-36709850 chr2:36709841-36709850 chr2:36709839-36709852 chr2:36709841-36709850

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:36689815-36689865	Caco-2	colon:	n/a
2	chr2:36696193-36696243	Jurkat	blood:	n/a
3	chr2:36696193-36696243	HRPEpiC	eye:	n/a
4	chr2:36706779-36706829	HRCEpiC	kidney:	n/a
5	chr2:36689815-36689865	ovcar-3	ovarian:	n/a
6	chr2:36696193-36696243	ProgFib	skin:	n/a
7	chr2:36696193-36696243	CMK	blood:	n/a
8	chr2:36712570-36712620	ovcar-3	ovarian:	n/a
9	chr2:36696193-36696243	HNPCEpiC	eye:	n/a
10	chr2:36706779-36706829	LNCaP	prostate:	n/a
11	chr2:36696193-36696243	K562	blood:	n/a
12	chr2:36688564-36688614	GM12891	blood:	n/a
13	chr2:36712570-36712620	HRCEpiC	kidney:	n/a
14	chr2:36688564-36688614	BE2_C	brain:	n/a
15	chr2:36696193-36696243	HEK293	kidney:	embryo
16	chr2:36689815-36689865	MCF10A-Er-Src	breast:	n/a
17	chr2:36689815-36689865	GM19239	blood:	n/a
18	chr2:36706779-36706829	GM12891	blood:	n/a
19	chr2:36712570-36712620	MCF10A-Er-Src	breast:	n/a
20	chr2:36706722-36706772	K562	blood:	n/a
21	chr2:36706722-36706772	CMK	blood:	n/a
22	chr2:36706779-36706829	HRPEpiC	eye:	n/a
23	chr2:36706779-36706829	NHDF-neo	bronchial:	n/a
24	chr2:36706722-36706772	NB4	blood:	n/a
25	chr2:36712570-36712620	NB4	blood:	n/a
26	chr2:36688564-36688614	AG09319	gingival:	n/a
27	chr2:36706722-36706772	SK-N-SH_RA	brain:	n/a
28	chr2:36689815-36689865	ECC-1	luminal epithelium:	n/a
29	chr2:36706722-36706772	SKMC	muscle:	n/a
30	chr2:36712570-36712620	NH-A	brain:	n/a
31	chr2:36712570-36712620	BE2_C	brain:	n/a
32	chr2:36689815-36689865	NH-A	brain:	n/a
33	chr2:36706722-36706772	Jurkat	blood:	n/a
34	chr2:36706722-36706772	AG09309	skin:	n/a
35	chr2:36689815-36689865	Hela-S3	cervix:	n/a
36	chr2:36688564-36688614	HEK293	kidney:	embryo
37	chr2:36706779-36706829	MCF10A-Er-Src	breast:	n/a
38	chr2:36706779-36706829	Hepatocyte	liver:	n/a
39	chr2:36712570-36712620	U87	brain:	n/a
40	chr2:36706779-36706829	IMR90	lung:	fetal
41	chr2:36706722-36706772	GM12878	blood:	n/a
42	chr2:36712570-36712620	HPAEpiC	pulmonary alveolar:	n/a
43	chr2:36688564-36688614	HPAEpiC	pulmonary alveolar:	n/a
44	chr2:36688564-36688614	Caco-2	colon:	n/a
45	chr2:36689815-36689865	HL-60	blood:	n/a
46	chr2:36689815-36689865	A549	lung:	n/a
47	chr2:36706722-36706772	HL-60	blood:	n/a
48	chr2:36696193-36696243	SK-N-SH_RA	brain:	n/a
49	chr2:36688564-36688614	HNPCEpiC	eye:	n/a
50	chr2:36696193-36696243	BE2_C	brain:	n/a

No.	Distal block	Cell Line	Cell type
1	chr2:36685298..36687775-chr2:36688130..36689743,2	MCF-7	breast:
2	chr2:36697741..36700351-chr2:36700679..36702284,2	MCF-7	breast:
3	chr2:36579116..36579764-chr2:36686740..36687372,2	MCF-7	breast:
4	chr2:36708521..36710689-chr2:36714441..36716853,2	K562	blood:
5	chr1:49284950..49287483-chr2:36706905..36709453,2	MCF-7	breast:
6	chr2:36701832..36704492-chr2:36708241..36710615,2	MCF-7	breast:
7	chr2:36685298..36687775-chr2:36688130..36689743,2	MCF-7	breast:
8	chr2:36706502..36708315-chr2:36708724..36710504,2	K562	blood:
9	chr2:36697741..36700351-chr2:36700679..36702284,2	MCF-7	breast:
10	chr2:36712172..36714860-chr2:36716725..36718248,2	K562	blood:
11	chr2:36582359..36584332-chr2:36684564..36688180,3	MCF-7	breast:
12	chr2:36579197..36579769-chr2:36686712..36687259,2	MCF-7	breast:
13	chr2:36701832..36704492-chr2:36708241..36710615,2	MCF-7	breast:
14	chr2:36703233..36705219-chr2:36822844..36824378,2	K562	blood:
15	chr2:36697131..36698011-chr20:52356873..52357556,2	MCF-7	breast:
16	chr2:36708521..36710689-chr2:36714441..36716853,2	K562	blood:

Variant related genes	Relation type
CRIM1	TF binding region
CRIM1	CpG island
ENSG00000150938	chromatin interactions

Extended variants
information (count: 1402 )
Associated
traits (count: 60 )

Variant overlapped rSNPs/rCNVs (count:1402 , 50 per page) page: 1 2 3 4 5 6 7 ... 29

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs888077	chr2:36687111-36687112	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs3770870	chr2:36687122-36687123	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs558626296	chr2:36687144-36687145	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs114908769	chr2:36687146-36687147	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs544472895	chr2:36687151-36687152	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs543663965	chr2:36687153-36687154	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs556441755	chr2:36687154-36687155	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs183830634	chr2:36687193-36687194	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs542041682	chr2:36687205-36687206	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs116595906	chr2:36687249-36687250	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs72865069	chr2:36687254-36687255	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs545780588	chr2:36687281-36687282	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs147786756	chr2:36687299-36687300	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs371192937	chr2:36687302-36687303	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs187220012	chr2:36687310-36687311	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs531597945	chr2:36687325-36687326	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs550029076	chr2:36687340-36687341	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs148542839	chr2:36687349-36687350	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs576878635	chr2:36687353-36687354	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs115982855	chr2:36687360-36687361	Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs529447348	chr2:36687424-36687425	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs548017248	chr2:36687451-36687452	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs191974018	chr2:36687457-36687458	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs540658800	chr2:36687518-36687519	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs533833342	chr2:36687538-36687539	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs75161496	chr2:36687609-36687610	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs145219350	chr2:36687648-36687649	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs10175022	chr2:36687670-36687671	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs183553306	chr2:36687725-36687726	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs574704549	chr2:36687733-36687734	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs535286527	chr2:36687747-36687748	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs553971310	chr2:36687766-36687767	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs187427911	chr2:36687809-36687810	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs147627500	chr2:36687810-36687811	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs34889913	chr2:36687877-36687878	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs564258342	chr2:36687890-36687891	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs139571197	chr2:36687935-36687936	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs543830572	chr2:36687951-36687952	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs191609487	chr2:36688059-36688060	Flanking Active TSS Enhancers Weak transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs371179645	chr2:36688063-36688064	Flanking Active TSS Enhancers Weak transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs529633259	chr2:36688111-36688112	Flanking Active TSS Enhancers Weak transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs527934463	chr2:36688121-36688122	Flanking Active TSS Enhancers Weak transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs116433364	chr2:36688141-36688142	Flanking Active TSS Enhancers Weak transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs533589691	chr2:36688142-36688143	Flanking Active TSS Enhancers Weak transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs549316278	chr2:36688145-36688146	Flanking Active TSS Enhancers Weak transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs367915407	chr2:36688155-36688156	Flanking Active TSS Enhancers Weak transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs182623384	chr2:36688191-36688192	Flanking Active TSS Enhancers Weak transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
48	rs530963895	chr2:36688215-36688216	Flanking Active TSS Enhancers Genic enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs149999192	chr2:36688220-36688221	Flanking Active TSS Enhancers Genic enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs115639534	chr2:36688231-36688232	Flanking Active TSS Enhancers Genic enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:60)

Disease	PMID	Source
Breast cancer	17393978	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Bladder cancer	21909424	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Leukemia	18628472	CNVD
Autism	19521722	CNVD
Autism	18522746	CNVD
Breast cancer	21364760	CNVD
Wilms tumour	21544195	CNVD
Non-small cell lung cancer	18927303	CNVD
Breast cancer	21785460	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	21965145	CNVD
Breast cancer	16397240	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21508638	CNVD
Neurodevelopmental disorder	22521361	CNVD
Neurocytoma	17123091	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
Pancreatic cancer	17952125	CNVD
T-cell lymphomas	22341440	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:1330 , 50 per page) page: 1 2 3 4 5 6 7 ... 27

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:36660800-36695600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
2	chr2:36668800-36690200	Genic enhancers	Breast Myoepithelial Primary Cells	Breast
3	chr2:36669200-36688200	Weak transcription	Thymus	Thymus
4	chr2:36669400-36688000	Weak transcription	Fetal Thymus	thymus
5	chr2:36670000-36688200	Weak transcription	Primary T cells from cord blood	blood
6	chr2:36672800-36688000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
7	chr2:36673600-36688000	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr2:36675400-36688000	Weak transcription	Placenta Amnion	Placenta Amnion
9	chr2:36678000-36688000	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
10	chr2:36678400-36688000	Enhancers	ES-I3 Cell Line	embryonic stem cell
11	chr2:36679000-36687600	Genic enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
12	chr2:36679200-36688400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
13	chr2:36679800-36687200	Genic enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
14	chr2:36679800-36704000	Weak transcription	Fetal Brain Female	brain
15	chr2:36680400-36695600	Weak transcription	Primary hematopoietic stem cells	blood
16	chr2:36682400-36688800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
17	chr2:36682600-36687800	Enhancers	HUES6 Cell Line	embryonic stem cell
18	chr2:36683000-36687600	Enhancers	HUES48 Cell Line	embryonic stem cell
19	chr2:36683400-36688200	Weak transcription	Primary B cells from cord blood	blood
20	chr2:36683400-36691400	Enhancers	H1 Cell Line	embryonic stem cell
21	chr2:36683800-36687800	Weak transcription	Liver	Liver
22	chr2:36683800-36688000	Genic enhancers	HUVEC	blood vessel
23	chr2:36683800-36690800	Genic enhancers	Osteobl	bone
24	chr2:36683800-36704000	Weak transcription	Pancreas	Pancrea
25	chr2:36684000-36687400	Weak transcription	Duodenum Smooth Muscle	Duodenum
26	chr2:36684000-36688200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
27	chr2:36684000-36695800	Weak transcription	Brain Inferior Temporal Lobe	brain
28	chr2:36684200-36687800	Weak transcription	Brain Angular Gyrus	brain
29	chr2:36684200-36687800	Weak transcription	Brain Hippocampus Middle	brain
30	chr2:36684200-36688000	Weak transcription	Psoas Muscle	Psoas
31	chr2:36684200-36688400	Weak transcription	Primary monocytes fromperipheralblood	blood
32	chr2:36684200-36695800	Weak transcription	Brain Substantia Nigra	brain
33	chr2:36684400-36691800	Enhancers	iPS-18 Cell Line	embryonic stem cell
34	chr2:36684600-36687600	Enhancers	iPS-20b Cell Line	embryonic stem cell
35	chr2:36684600-36688000	Genic enhancers	NHLF	lung
36	chr2:36684800-36687600	Strong transcription	Placenta	Placenta
37	chr2:36684800-36688000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
38	chr2:36684800-36691800	Weak transcription	Fetal Muscle Leg	muscle
39	chr2:36684800-36694000	Weak transcription	Fetal Brain Male	brain
40	chr2:36684800-36695800	Weak transcription	Fetal Muscle Trunk	muscle
41	chr2:36685000-36691600	Enhancers	iPS-15b Cell Line	embryonic stem cell
42	chr2:36685200-36687200	Strong transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
43	chr2:36685200-36689400	Genic enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
44	chr2:36685600-36690400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
45	chr2:36685800-36687800	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
46	chr2:36685800-36689800	Genic enhancers	Hela-S3	cervix
47	chr2:36686000-36688000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
48	chr2:36686000-36688200	Enhancers	HUES64 Cell Line	embryonic stem cell
49	chr2:36686000-36689200	Genic enhancers	HepG2	liver
50	chr2:36686200-36687200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links